Status:
COMPLETED
Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
This is an observational prospective, multicenter study. The aim of the study is to evaluate how the Italian population of patients are treated with early aggressive RA, defined by the Italian Society...
Detailed Description
It was expected that approximate 200 patients were enrolled in the study. Have been enrolled 152 patients. A Statistical Analysis Plan will contain a detailed description of criteria for valuable pati...
Eligibility Criteria
Inclusion
- Inclusion Criteria Based On Clinical Practice of Aggressive RA
- Diagnosis of early aggressive RA in accordance with local guideline
- Disease duration \< 2 years and at least six months since onset of symptoms
- Patients naïve to anti-TNFa drugs and DMARDs, including MTX, or assuming one or more DMARD without complete response
Exclusion
- Exclusion Criteria Based on Clinical Practice of Aggressive RA
- Patients should not be included in the study if they have participated in any interventional clinical trial within the previous 2 years.
Key Trial Info
Start Date :
April 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT00267852
Start Date
April 1 2006
End Date
July 1 2010
Last Update
September 15 2011
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Iesi, Ancona, Italy, 60035
2
Pfizer Investigational Site
Bari, Apulia, Italy, 70124
3
Pfizer Investigational Site
Napoli, Campania, Italy, 80131
4
Pfizer Investigational Site
Ferrara, Ferrara (FE), Italy, 44100